Copyright: ©Author(s) 2026.
World J Psychiatry. Oct 19, 2026; 16(10): 121314
Published online Oct 19, 2026. doi: 10.5498/wjp.121314
Published online Oct 19, 2026. doi: 10.5498/wjp.121314
Table 3 Descriptive summary of clinical variables and observed laboratory measures1
| Variable | Unit | Missing (n) | Missing (%) | mean ± SD | Distribution |
| Glycemic exposures | |||||
| FPG | mmol/L | 0 | 0 | 6.5 ± 3.0 | 5.6 (5.0-6.8) |
| FA | mmol/L | 0 | 0 | 1.7 ± 0.4 | 1.6 (1.5-1.8) |
| HbA1c | % | 0 | 0 | 5.7 ± 1.0 | 5.4 (5.2-5.8) |
| FA-ALBcorr | 4 | 0.08 | 3.90 ± 0.82 | 3.72 (3.42-4.12) | |
| Outcomes | |||||
| D-dimer | μg/mL | 663 | 13.32 | 0.3 ± 0.8 | 0.1 (0.1-0.3) |
| log(D-dimer) | 663 | 13.32 | 0.24 ± 0.29 | 0.14 (0.06-0.29) | |
| D-dimer (+) | 663 | 13.32 | 622 (14.4) | ||
| Components/derived measures | |||||
| TG | mmol/L | 3 | 0.06 | 1.7 ± 1.4 | 1.3 (0.9-2.0) |
| TC | mmol/L | 70 | 1.41 | 4.5 ± 1.0 | 4.4 (3.8-5.0) |
| LDL-C | mmol/L | 3 | 0.06 | 2.6 ± 0.9 | 2.5 (2.0-3.1) |
| HDL-C | mmol/L | 3 | 0.06 | 1.3 ± 0.4 | 1.3 (1.1-1.5) |
| SBP | mmHg | 1 | 0.02 | 125 ± 17 | 124 (114-135) |
| DBP | mmHg | 1 | 0.02 | 80 ± 11 | 80 (72-87) |
| Hb | g/L | 33 | 0.66 | 135 ± 16 | 134 (125-146) |
| PAB | mg/L | 5 | 0.1 | 286 ± 73 | 278 (236-327) |
| TP | g/L | 4 | 0.08 | 70 ± 6 | 71 (66-74) |
| ALB | g/L | 4 | 0.08 | 44 ± 4 | 44 (41-47) |
| FIB | g/L | 641 | 12.88 | 2.7 ± 0.7 | 2.6 (2.2-3.0) |
| PLT | × 109/L | 33 | 0.66 | 239 ± 69 | 233 (193-281) |
| APTT | seconds | 641 | 12.88 | 28.8 ± 4.9 | 28.1 (25.8-31.0) |
| PT | seconds | 641 | 12.88 | 11.4 ± 1.3 | 11.3 (10.8-11.9) |
| TT | seconds | 641 | 12.88 | 15.3 ± 3.9 | 16.8 (11.1-18.6) |
| ALT | U/L | 0 | 0 | 25 ± 26 | 17 (12-27) |
| AST | U/L | 0 | 0 | 24 ± 19 | 19 (16-25) |
| GGT | U/L | 73 | 1.47 | 25 ± 30 | 17 (12-27) |
| ALP | U/L | 5 | 0.1 | 81 ± 32 | 75 (61-93) |
| TBIL | µmol/L | 1 | 0.02 | 10.5 ± 6.3 | 8.9 (6.4-12.6) |
| DBIL | µmol/L | 2 | 0.04 | 3.1 ± 2.3 | 2.5 (1.8-3.6) |
| BUN | mmol/L | 1 | 0.02 | 4.8 ± 1.8 | 4.5 (3.7-5.6) |
| Cr | µmol/L | 1 | 0.02 | 63.6 ± 17.1 | 61.0 (53.0-72.0) |
| WBC | × 109/L | 33 | 0.66 | 7.3 ± 2.4 | 6.9 (5.6-8.6) |
| CRP | mg/L | 612 | 12.3 | 3.1 ± 9.0 | 0.8 (0.5-2.5) |
| SAA | mg/L | 37 | 0.74 | 13.6 ± 38.1 | 5.8 (3.9-9.5) |
| LDH | U/L | 3 | 0.06 | 173 ± 47 | 164 (144-190) |
| NEU | × 109/L | 101 | 2.03 | 4.8 ± 2.1 | 4.3 (3.3-5.8) |
| MONO | × 109/L | 101 | 2.03 | 0.5 ± 0.2 | 0.5 (0.4-0.6) |
| LYM | × 109/L | 101 | 2.03 | 1.9 ± 0.7 | 1.8 (1.4-2.3) |
| AIP | 3 | 0.06 | 0.02 ± 0.31 | 0.00 (-0.20-0.23) | |
| SIRI | 101 | 2.03 | 1.56 ± 1.57 | 1.12 (0.71-1.84) | |
| CONUT | 105 | 2.11 | |||
| Normal (0-1) | 4144 (85.1) | ||||
| Mild malnutrition (2-4) | 721 (14.8) | ||||
| Moderate severe (5-8) | 6 (0.1) | ||||
| PNI | 105 | 2.11 | 53.4 ± 5.5 | 53.2 (49.6-56.8) | |
| Covariates | |||||
| Age | years | 0 | 0 | 41 ± 18 | 39 (26-56) |
| Gender, male | 0 | 0 | 1762 (35.4) | ||
| BMI | kg/m2 | 0 | 0 | 23.1 ± 4.3 | 22.7 (20.1-25.5) |
| Hypertension (+) | 0 | 0 | 893 (17.9) | ||
| Diabetes (+) | 0 | 0 | 595 (12.0) | ||
| Hyperlipidemia (+) | 0 | 0 | 210 (4.2) | ||
| Smoking Status | 0 | 0 | |||
| No history | 4189 (84.2) | ||||
| Current | 705 (14.2) | ||||
| Former | 82 (1.6) | ||||
| Alcohol Status | 0 | 0 | |||
| No history | 4312 (86.7) | ||||
| Current | 629 (12.6) | ||||
| Former | 35 (0.7) | ||||
| Body temperature (+) | 0 | 0 | 912 (18.3) | ||
| Psychiatric duration | years | 0 | 0 | 9 ± 10 | 5 (1-12) |
- Citation: Wei J, Du HY, He Q, Jia SS, Luo FG, Wang YC. Glycemic indicators influence hypercoagulability via multisystem pathways in psychiatric inpatients: Structural equation modeling. World J Psychiatry 2026; 16(10): 121314
- URL: https://www.wjgnet.com/2220-3206/full/v16/i10/121314.htm
- DOI: https://dx.doi.org/10.5498/wjp.121314